Eskom CEO André de Ruyter leaves with immediate effect | Top-end Discovery medical aid plans to increase by 10% and more
| | | | | | | Today on MoneywebNOW | | Lonwabo Maqubela from Perpetua Investment Managers unpacks the strong Standard Bank trading update, albeit with base effect. Are banks offering value? Maarten Ackerman from Citadel reviews the budget. Livestream at 6:30am » | | |
|
|
| | Top stories | | | | | | | | Sars ups revenue collection forecast by R10.3bn | | Fifi Peters | | 'Large businesses and international businesses are buoying up our compliance levels, but we think we have a long way to go in terms of the SMME segment’: Johnstone Makhubu – chief revenue officer, Sars. |
|
| | Brought to you by Investec | | A better budget than expected | | Ciaran Ryan | | It provides tax relief for working South Africans while restructuring Eskom debt – all in a low-growth environment. |
|
| | |
|
| | | | | | | | | | | | | | | | | | | | Current Value | Move % | | USDZAR | 18.20 23 Feb, 5:11 | -0.22 % | | EURZAR | 19.34 23 Feb, 5:11 | -0.06 % | | GBPZAR | 21.96 23 Feb, 5:11 | -0.07 % | | BTCUSD | 24,534.50 23 Feb, 5:10 | 3.11 % |
|
|
| Current Value | Move % | | JSE ALSI | 78,170 23 Feb 00:00 | -0.81% | | S&P500 | 3,991.05 22 Feb, 0:00 | -0.16% | | Dow Jones | 33,045.09 22 Feb, 0:00 | -0.26% | | BRENT | 80.78 23 Feb, 5:00 | 0.65% |
|
|
|
| Winners: 36/100 | Current Value | Move % | 7 Day Move | 30 Day Move | | MNTKRENEW » | 190.35 22 Feb, 17:06 | 5.14 % | -2.40% | -7.43% | | STANBANK » | 184.13 22 Feb, 17:02 | 3.88 % | -0.33% | 2.22% | | QUILTER » | 20.73 22 Feb, 17:06 | 2.88 % | 0.75% | -2.28% |
| Losers: 62/100 | Current Value | Move % | 7 Day Move | 30 Day Move | | ALPHAMIN » | 11.02 22 Feb, 16:31 | -15.17 % | 4.09 % | 3.10 % | | ANGGOLD » | 308.51 22 Feb, 17:09 | -7.08 % | -5.86 % | -13.54 % | | HARMONY » | 54.97 22 Feb, 17:10 | -6.83 % | -2.48 % | -9.85 % | | The winners and losers are ranked by the market performance of the latest trading day of the top 100 JSE-listed companies by market capitalisation. |
|
|
| | | | | | Get full access to all our market indicators, investment tools and award‑winning articles. | | R63/month or R630/year | | | | You can cancel at any time. |
|
| | | | |
|
